跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
HYRIMOZ SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 20MG/0.2ML
Approved
THERAPEUTIC
HYRIMOZ SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 20MG/0.2ML
Novartis Pharmaceutical Manufacturing GmbH (Langkampfen) (AUSTRIA)
🇸🇬 Health Sciences Authority
Approval Date
Dec 11, 2025
Approval ID
94efc2a80a24a299
Company
Novartis Pharmaceutical Manufacturing GmbH (Langkampfen) (AUSTRIA)
Type
Therapeutic
Approval Details
Approval Id
94efc2a80a24a299
Drug Name
HYRIMOZ SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 20MG/0.2ML
Product Name
HYRIMOZ SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 20MG/0.2ML
Approval Number
SIN17414P
Approval Date
2025-12-11
Registrant
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
SUBCUTANEOUS
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 11, 2025
Approval ID
94efc2a80a24a299
Type
Therapeutic
Back to HSA Approvals
HYRIMOZ SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 20MG/0.2ML - HSA Drug Approval Details
